欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/1270/002
药品名称Cloreto de Potássio e Glucose Kabi
活性成分
    • glucose monohydrate 55.0 mg
    • potassium chloride 3.0 mg
剂型Solution for infusion
上市许可持有人Fresenius Kabi Pharma Portugal, Lda.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Belgium (BE)
      Kaliumchloride 0.3% + Glucose 5% Fresenius Kabi oplossing voor infusie
    • Netherlands (NL)
      Kaliumchloride 0.3% - Glucose 5% Fresenius Kabi, oplossing voor infusie
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Poland (PL)
    • Latvia (LV)
      Potassium Chloride/Glucose Fresenius 3 mg/50 mg/ml šķīdums infūzijām
    • Lithuania (LT)
      Potassium chloride/Glucose Fresenius 3 mg/50 mg/ml infuzinis tirpalas
    • Estonia (EE)
      POTASSIUM CHLORIDE/GLUCOSE FRESENIUS 3 MG/50 MG/ML
许可日期2015/04/22
最近更新日期2024/04/02
药物ATC编码
    • B05BB02 electrolytes with carbohydrates
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase